Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedAug 09, 2026
DataAggregated Company Financials
Companies16
  • 7D-3.0%
  • 3M-5.1%
  • 1Y14.6%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 3.0%, driven by AstraZeneca declining 5.8%. In the past year, the industry has gained 15%. Looking forward, earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 09 Aug 2026UK£301.3bUK£92.9bUK£14.4b21.9x20.9x3.2x
Tue, 07 Jul 2026UK£335.0bUK£92.1bUK£15.8b19x21.2x3.6x
Thu, 04 Jun 2026UK£312.8bUK£92.0bUK£15.8b17.1x19.8x3.4x
Sat, 02 May 2026UK£329.4bUK£91.3bUK£15.7b18.4x21x3.6x
Mon, 30 Mar 2026UK£341.2bUK£91.1bUK£15.7b19.7x21.7x3.7x
Wed, 25 Feb 2026UK£368.0bUK£90.1bUK£15.4b23.3x23.9x4.1x
Fri, 23 Jan 2026UK£322.1bUK£89.3bUK£14.6b22.1x22.1x3.6x
Sun, 21 Dec 2025UK£323.8bUK£89.7bUK£14.6b21.9x22.1x3.6x
Tue, 18 Nov 2025UK£321.8bUK£90.4bUK£14.8b21.6x21.8x3.6x
Thu, 16 Oct 2025UK£298.2bUK£87.9bUK£11.7b20x25.4x3.4x
Sat, 13 Sep 2025UK£282.1bUK£87.3bUK£11.7b21.2x24.2x3.2x
Mon, 11 Aug 2025UK£263.7bUK£87.7bUK£11.7b21.5x22.5x3x
Wed, 09 Jul 2025UK£257.6bUK£86.2bUK£10.6b25.6x24.3x3x
Fri, 06 Jun 2025UK£270.4bUK£86.2bUK£10.6b27.1x25.5x3.1x
Sun, 04 May 2025UK£268.3bUK£87.4bUK£10.7b26.7x25x3.1x
Tue, 01 Apr 2025UK£276.2bUK£87.7bUK£9.7b32x28.4x3.1x
Thu, 27 Feb 2025UK£287.9bUK£88.5bUK£9.4b31.4x30.6x3.3x
Sat, 25 Jan 2025UK£234.4bUK£75.6bUK£7.8b33x30x3.1x
Mon, 23 Dec 2024UK£220.2bUK£75.3bUK£7.8b30.8x28.3x2.9x
Wed, 20 Nov 2024UK£215.8bUK£75.0bUK£7.7b30.3x27.9x2.9x
Fri, 18 Oct 2024UK£255.3bUK£72.4bUK£9.1b30.9x28.2x3.5x
Sun, 15 Sep 2024UK£259.0bUK£72.1bUK£9.0b37.7x28.7x3.6x
Tue, 13 Aug 2024UK£270.3bUK£73.2bUK£9.1b39.3x29.6x3.7x
Thu, 11 Jul 2024UK£255.8bUK£71.1bUK£9.5b27.8x27x3.6x
Sat, 08 Jun 2024UK£268.8bUK£71.5bUK£9.6b30.5x28.1x3.8x
Mon, 06 May 2024UK£265.3bUK£72.0bUK£9.6b32.9x27.6x3.7x
Wed, 03 Apr 2024UK£241.9bUK£71.0bUK£9.7b31.6x24.9x3.4x
Fri, 01 Mar 2024UK£231.8bUK£70.8bUK£9.8b30.8x23.8x3.3x
Sun, 28 Jan 2024UK£237.3bUK£68.9bUK£10.7b35.9x22.2x3.4x
Tue, 26 Dec 2023UK£232.3bUK£68.9bUK£10.7b34.8x21.8x3.4x
Thu, 23 Nov 2023UK£225.1bUK£69.7bUK£10.8b54.4x20.9x3.2x
Sat, 21 Oct 2023UK£234.8bUK£70.7bUK£10.4b53.5x22.7x3.3x
Mon, 18 Sep 2023UK£245.3bUK£70.0bUK£10.3b53.5x23.8x3.5x
Wed, 16 Aug 2023UK£238.8bUK£69.0bUK£10.2b53.5x23.5x3.5x
Price to Earnings Ratio

23.5x


Total Market Cap: UK£238.8bTotal Earnings: UK£10.2bTotal Revenue: UK£69.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 24.8x202420252026
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.9x which is lower than its 3-year average PE of 24.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 10% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.K. Pharma compare with similar industries?

GB Market0.89%
Healthcare-2.83%
Pharma-3.03%
Pharma-3.03%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£19.611.5%
+UK£1.2b		40.5%PE16.3x
HLN HaleonUK£3.691.7%
+UK£537.3m		4.0%PE20x
HIK Hikma PharmaceuticalsUK£16.775.8%
+UK£193.5m		-3.6%PE12.3x
HCM HUTCHMED (China)UK£1.848.2%
+UK£121.7m		-18.0%PE120.7x
POLB Poolbeg PharmaUK£0.08323.9%
+UK£12.2m		225.5%PB7.4x

Latest News

HIK
UK£16.77
Hikma Pharmaceuticals
7D
5.8%
1Y
-3.6%
AZN
UK£118.96
AstraZeneca
7D
-5.8%
1Y
8.9%
HCM
UK£1.84
HUTCHMED (China)
7D
8.2%
1Y
-18.0%
Narrative Update • Aug 07

HCM: Upcoming China Approvals And Profitability Challenges Will Shape Future Share Repricing

Analysts have reduced their HUTCHMED (China) price target from £2.03 to £1.75, citing updated assumptions that include a higher discount rate, a revised profit margin outlook and a significantly higher future P/E multiple in their models. What’s in the News for HUTCHMED (China) HUTCHMED (China) reiterated consolidated revenue guidance for full year 2026 in a range of US$330 million to US$450 million.
HLN
UK£3.69
Haleon
7D
1.7%
1Y
4.0%
EAH
UK£0.98
ECO Animal Health Group
7D
-1.5%
1Y
33.1%
GSK
UK£19.61
GSK
7D
1.5%
1Y
40.5%
Narrative Update • Aug 05

GSK: Oncology Pipeline Rebuild And Product Relaunch Plans Will Drive Future Upside

Analysts have raised their fair value estimate for GSK, increasing the target from £28.25 to about £29.32 as they incorporate new Street research on pipeline rebuilding efforts, the planned Brexafemme relaunch and recent acquisition activity. Analyst Commentary Recent research on GSK points to a more constructive tone from bullish analysts, especially around efforts to rebuild the pipeline and progress toward a Brexafemme relaunch.
STX
UK£0.038
Shield Therapeutics
7D
-3.8%
1Y
-17.4%
FUM
UK£0.0034
Futura Medical
7D
-18.7%
1Y
-96.4%
AGY
UK£0.055
Allergy Therapeutics
7D
-8.0%
1Y
-37.1%
POLB
UK£0.083
Poolbeg Pharma
7D
23.9%
1Y
225.5%
INC
UK£0.011
Incanthera
7D
-8.0%
1Y
-81.6%
IMM
UK£0.04
ImmuPharma
7D
11.7%
1Y
153.2%
NFX
UK£0.0013
Nuformix
7D
-9.0%
1Y
55.3%